Evidence map›Paper›PMID 34041662›Full record

ArticleVeterinary research communications2021

Multi-drug resistant (MDR), extended spectrum beta-lactamase (ESBL) producing and carbapenem resistant Escherichia coli in rescued Sloth bears (Melursus ursinus), India.

O R VinodhKumar, M Karikalan, S Ilayaraja, Arun A Sha, B R Singh, D K Sinha, S Chandra Mohan, B S Pruthvishree, A M Pawde, A K Sharma

Abstract read
PubMed Publisher
In one paragraph

Article in Veterinary research communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. ESBL-ProducingVeterinary sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Synergistic Activity of Tetrandrine and Colistin againstAntibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

O R VinodhKumarDivision of Epidemiology, ICAR- Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, 243122, India. vinodhkumar.rajendran@gmail.com.ORCID http://orcid.org/0000-0002-7232-4122
M KarikalanCentre for Wildlife, ICAR- Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, 243122, India.
S IlayarajaAgra Bear Rescue Centre, Wildlife SOS, Keetham, Agra, Uttar Pradesh, India.
Arun A ShaResearch &Veterinary Operations, Bannerghatta Bear Rescue Centre, Wildlife SOS, Bengaluru, India.
B R SinghDivision of Epidemiology, ICAR- Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, 243122, India.
D K SinhaDivision of Epidemiology, ICAR- Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, 243122, India.
S Chandra MohanCentre for Wildlife, ICAR- Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, 243122, India.
B S PruthvishreeDivision of Epidemiology, ICAR- Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, 243122, India.
A M PawdeCentre for Wildlife, ICAR- Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, 243122, India.
A K SharmaCentre for Wildlife, ICAR- Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, 243122, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study reports the multi-drug resistant (MDR), extended spectrum beta-lactamase (ESBL) producing and carbapenem resistant Escherichia coli (CRE) isolated from rescued sloth bear (Melursus ursinus), India. Non-duplicate faecal samples from 21 adult rescued sloth bears were collected at once during 2015-2016 and processed for isolation of E. coli and antibacterial susceptibility pattern. From 21 samples, 45 E. coli were isolated and on phenotypic screening, 23 were MDR, 17 were ESBL producers, and five were carbapenem-resistant (CR). Three E. coli isolates (6.67%, 3/45) showed no resistance, however 42 isolates (93.33%, 42/45) exhibited resistant to at least one antibiotics. The MDR isolates carried beta-lactamase, chloramphenicol, aminoglycosides, tetracycline, fluroquinolone, and sulphadimidine resistance genes. All the phenotypic ESBL producing isolates harbored blaCTX-M genes. On genotypic screening, three CRE (60.0%, 3/5) were positive for blaNDM carbapenemase gene and efflux pump-mediated carbapenem resistance was detected in two CRE isolates (40.0%, 2/5) which were negative for carbapenemase genes. The CRE isolates (n = 5) also co-harbored AMR genes like blaTEM-1, blaAmpC, qnrA, qnrB, qnrS, tetA, tetB and sulI. Virulence screening of the resistant isolates detected the presence of Stx1(n = 1), Stx2 (n = 3), eaeA (n = 4) and hlyA (n = 3) genes. Plasmid incompatibility (Inc) typing revealed that two isolates harboured blaNDM-5 gene on Incl1 and one isolate on IncF plasmid. Apart from the NDM gene, the plasmids also carried tetracycline, beta-lactamase and quinolone resistance genes. The plasmid multilocus sequence typing (pMLST) of the E. coli Incl1 plasmid showed the Sequence Type (ST) 297. This appears to be the first report of MDR, ESBL producing and blaNDM-5 genes on Incl1 and IncF plasmids from rescued sloth bear.

Indexed as

Drug Resistance, Multiple, BacterialUrsidaeAnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCross-Sectional StudiesEscherichia coliEscherichia coli InfectionsIndiaAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemE. coliESBLSloth bearVirulence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.